UBS Group’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HLGN.WS
UBS Group's HLGN.WS Position: Q4 2023 in Review
UBS Group sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q4 2023, closing a stake of 107 shares — an estimated $4 sold.
UBS Group first reported a position in HLGN.WS in Q4 2022 and held it in 3 quarters. The position peaked at $3.32K in Q4 2022. 3 funds tracked by Wall St. Rank hold HLGN.WS as of Q4 2023.
- UBS Group reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q4 2023 after selling out during the quarter.
- UBS Group sold 107 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q4 2023, an estimated $4.
- UBS Group first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2022 and held it in 3 quarters.
- UBS Group's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $3.32K in Q4 2022.
- 3 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q4 2023.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.